| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP & Chief Scientific Officer | Executive VP & Chief Scientific Officer
1 company
Aby J. Mathew is EVP & Chief Scientific Officer at BLFS. From February 2020 to October 2026, the filings on record show 0 open-market purchases and 102 sales. Aby J. Mathew's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Historically, Aby J. Mathew's trades have earned a middling insider score of 67/100 across 112 rated trades. Over a 12-month horizon, 67.6% of those trades were profitable, with an average 12-month return of +9.0%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2020 | BLFS Biolife Solutions Inc | Executive VP & Chief Scientific Officer | Sell | 1,024 | $15.02 | $15,380.48 | -0.5% | |
| Feb 5, 2020 | BLFS Biolife Solutions Inc | Executive VP & Chief Scientific Officer | Sale+OE | 30,000 | $13.93 | $417,900.00 | -13.6% |